| MR编号 | SI/H/0174/001 |
|---|
| 药品名称 | Ertapenem AptaPharma 1 g powder for concentrate for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Powder for concentrate for solution for infusion |
|---|
| 上市许可持有人 | Apta Medica Internacional d.o.o.
Likozarjeva ulica 6
Ljubljana
1000
Slovenia |
|---|
| 参考成员国 - 产品名称 | Slovenia (SI) Ertapenem AptaPharma 1 g prašek za koncentrat za raztopino za infundiranje |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
- Czechia (CZ)
Ertapenem Aptapharma - Netherlands (NL)
- Poland (PL)
Ertapenem AptaPharma - Sweden (SE)
- Romania (RO)
Ertapenem Aptapharma 1 g pulbere pentru concentrat pentru soluție perfuzabilă - Norway (NO)
- Bulgaria (BG)
Ertapenem AptaPharma 1 g - Finland (FI)
- Cyprus (CY)
Ertapenem Aptapharma 1gr powder for concentrate for solution for infusion - Austria (AT)
Ertapenem AptaPharma 1 g Pulver für ein Konzentrat zur Herstellung einer Infusionslösung - Malta (MT)
- Hungary (HU)
ERTAPENEM APTAPHARMA 1 g por oldatos infúzióhoz való koncentrátumhoz - Croatia (HR)
Ertapenem AptaPharma 1 g prašak za koncentrat za otopinu za infuziju - Slovakia (SK)
|
|---|
| 许可日期 | 2017/12/21 |
|---|
| 最近更新日期 | 2024/11/13 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|